KUALA LUMPUR: No cases of stroke were reported in clinic studies for the Comirnaty bivalent Covid-19 vaccine, according to data submitted by product registration holder Pfizer Sdn Bhd to the National Pharmaceutical Regulatory Agency (NPRA).
Health director-general Tan Sri Dr Noor Hisham Abdullah (pic) said so far there were also no safety signals of ischaemic stroke detected through other safety monitoring systems in the United States following the use of the Pfizer bivalent vaccine.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
